2002 – Janssen issues warning letter

Announcement Date: January 1, 2002


Janssen Pharmaceuticals issues a warning letter to Health Canada regarding the risks associated with prescribing Risperdal to elderly patients. FDA is not issued this warning until the following year. Also in 2002, Risperdal is linked to at least 37 cases of stroke-like events including 16 deaths.